| | |
CYP26A1 expression
| |
|---|
|
Variables
|
Cases (n)
|
Negative (%)
|
Positive (%)
|
P
|
|---|
|
Age (years)
| | | | |
|
<60
|
59
|
31 (52.5)
|
28 (47.5)
|
0.136
|
|
≥60
|
61
|
41 (67.2)
|
20 (32.8)
| |
|
Sex
| | | | |
|
Male
|
104
|
61 (58.7)
|
43 (41.3)
|
0.586
|
|
Female
|
16
|
11 (68.8)
|
5 (31.2)
| |
|
Primary tumor status (pT)
| | | | |
|
pT1
|
9
|
6 (66.7)
|
3 (33.3)
|
0.025*
|
|
pT2
|
38
|
25 (65.8)
|
13 (34.2)
| |
|
pT3
|
35
|
25 (71.4)
|
10 (28.6)
| |
|
pT4
|
34
|
13 (38.2)
|
21 (61.8)
| |
|
Lymph node involvement (pN)
| | | | |
|
Absent
|
65
|
40 (61.5)
|
25 (38.5)
|
0.574
|
|
Present
|
52
|
29 (55.8)
|
23 (44.2)
| |
|
Distant metastasis (M)
| | | | |
|
Absent
|
115
|
69 (60.0)
|
46 (40.0)
|
1.000
|
|
Present
|
4
|
2 (50.0)
|
2 (50.0)
| |
|
pTNM stage
| | | | |
|
pStage I
|
7
|
5 (71.4)
|
2 (28.6)
|
0.015*
|
|
pStage II
|
26
|
18 (69.2)
|
8 (30.8)
| |
|
pStage III
|
35
|
26 (74.3)
|
9 (25.7)
| |
|
pStage IV
|
49
|
21 (42.9)
|
28 (57.1)
| |
- *Significantly different by the chi-square (χ2) test.
- Abbreviations: CYP26A1, cytochrome P450, family 26, subfamily A, polypeptide 1; pTNM, pathological tumor-node-metastasis.
